Central Laboratories Applications & Studies

  1. Case Study – Leading Pharma Enrolls 56% Faster With WCG Site Augmentation 9/8/2021

    A leading sponsor initiated a time-critical and complex adult Staphylococcus vaccine study. Per the protocol design, this global study needed to address patient identification and coordination of communication pathways for referral networking. The study also required real-time review of daily surgical schedules to assess patients’ eligibility.

  2. Visual Analytics And Discovery Platform For Scientific And Clinical R&D 8/18/2021

    A pharmaceutical company was looking to deploy a software solution for a small R&D group. See how an enterprise-class visualization and analytics platform enabled maximized understanding of research data.

  3. UW Carbone Cancer Center Gains Visibility Into Site Accrual 5/11/2021

    Monitoring accrual is a key responsibility for a cancer center administrator. From answering questions for leadership to preparing for a grant submission, knowing the ins and outs of a site’s accrual metrics can ensure greater operational efficiencies center-wide. Read how UWCCC was able to enhance their data analytics and visualization capabilities helping them improve operational oversight, especially through greater visibility into site accrual metrics.

  4. Preparing Data For The Marketing Authorization Application (MAA) Of A Recently Acquired Product 4/28/2021

    A mid-sized biopharmaceutical company dedicated to developing innovative therapies for patients with debilitating rare diseases acquired the rights to a new investigational drug from a large pharmaceutical company with the intention of preparing the data for a Marketing Authorization Application (MAA). Learn how our team had to think creatively to enter, clean and standardize the clinical trial data from previous and ongoing trials in order to get the MAA ready for submission in an extremely short timeline.

  5. Real World Data: Extensive Searchable Selection Tables For Sites In A Study With 15,000 Patients 4/7/2021

    A top 5 Pharma company was collecting data for a global disease registry from over 10,000 patients. To avoid collecting “free text” they wanted the study sites to use extensive “pick lists”. These lists consisted of over 12,000 unique options so could not be just simple lists. Cmed was able to provide a solution that would enable site staff to review, filter and select the required option.

  6. Reduce Time, Cost, & Risk With Clinical Study Data Review Software 1/22/2021

    See how a top 10 global biopharmaceutical company implemented a single data review system to reduce the time, cost, and risk of running its clinical trials while accelerating the time to market.

  7. Remote Work Without VPN Helps Biopharmaceutical Company Keep Drug Development On Track 12/7/2020

    Travere Therapeutics is a San Diego, CA-based biopharmaceutical company that develops life-changing therapies for people living with rare diseases. When it transitioned to a primarily remote workforce in 2015, it needed to keep its work moving forward at the same speed. Accessing the cloud-share via VPN from one end of the country to another wasn’t just painfully slow, their people were losing connection, too. They needed a solution that would help keep drug development on track regardless of the location of each team.

  8. A Global Observational Registry Of Adult Patients With Homozygous Familial Hypercholesterolemia (HoFH) 8/5/2020

    Clinical development service provider efficiently and strategically manages a global rare disease registry with rolling start-up, including mandated annual data collection and reporting.

  9. Key To A Faster, More Flexible Clinical Trial Process 7/24/2020

    Discover how a single, integrated data analytics and visualization platform, supported by an experienced partner, can help you move your investigational product to market more quickly.

  10. Delivering The Global Expertise Required To Coordinate A Pediatric Gene Therapy Trial 5/4/2020

    A European biotech company was conducting a pediatric trial involving a rare, incurable genetic disorder. In addition to new regulatory considerations, this trial also called for an extremely challenging intracerebral administration. To succeed, they needed a partner that could develop a clear, compliant strategy for obtaining informed consent and implementing an innovative data management plan to track patients between surgical and clinical sites.